Search
notch-2 (Drosophila) homolog protein (NOTCH2)
Function:
- functions as a receptor for membrane-bound ligands Jagged1, Jagged2 & delta1 to regulate cell-fate determination
- upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBP-J kappa & activates genes of the enhancer of split locus
- affects implementation of differentiation, proliferation & apoptotic programs (putative)
- synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form
- cleavage results in a C-terminal fragment N(TM) & a N-terminal fragment N(EC)
- following ligand binding, it is cleaved by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT)
- this fragment is then cleaved by presenilin dependent gamma-secretase to release a notch-derived peptide containing the intracellular domain (NICD) from the membrane (putative)
- phosphorylated (putative)
- heterodimer of a C-terminal fragment N(TM) & an N-terminal fragment N(EC) which are probably linked by disulfide bonds (putative)
- interacts with MAML1, MAML2 & MAML3 which act as transcriptional coactivators for NOTCH2
Structure:
- belongs to the NOTCH family
- contains 6 ANK repeats
- contains 35 EGF-like domains
- contains 3 LNR (lin/notch) repeats
Compartment:
- cell membrane; single-pass type 1 membrane protein
- notch 2 intracellular domain: nucleus
- following proteolytical processing NICD is translocated to the nucleus
Expression:
- expressed in the brain, heart, kidney, lung, skeletal muscle & liver
Pathology:
- defects in NOTCH2 are the cause of Alagille syndrome type 2
General
ankyrin repeat domain protein (ANKRD)
glycoprotein
notch (Drosophila) homolog protein
phosphoprotein
Properties
SIZE: entity length = 2471 aa
MW = 265 kD
COMPARTMENT: cell nucleus
cellular membrane
MOTIF: signal sequence {1-25}
EGF domain {26-1412} (35)
Notch/Lin12 repeat {1425-1544} (3)
cysteine residue {C1503}
MODIFICATION: cysteine residue {C1527}
cysteine residue {C1509}
MODIFICATION: cysteine residue {C1522}
cysteine residue {C1518}
MODIFICATION: cysteine residue {C1534}
cysteine residue {C1522}
MODIFICATION: cysteine residue {C1509}
cysteine residue {C1527}
MODIFICATION: cysteine residue {C1503}
cysteine residue {C1534}
MODIFICATION: cysteine residue {C1518}
cysteine residue {C1632}
MODIFICATION: cysteine residue {C1639}
cysteine residue {C1639}
MODIFICATION: cysteine residue {C1632}
transmembrane domain
ankyrin repeat
NAME: ankyrin repeat (6)
transmembrane domain {1678-1698}
Thr phosphorylation site {T1716}
Ser phosphorylation site {S1778}
Thr phosphorylation site {T1802}
Ser phosphorylation site {S1804}
Thr phosphorylation site {T1808}
ankyrin repeat
NAME: ankyrin repeat
SITE: 1827-1871
MOTIF: Ser phosphorylation site {S1841}
Ser phosphorylation site {S1842}
Ser phosphorylation site {S1845}
ankyrin repeat
NAME: ankyrin repeat
SITE: 1876-1905
ankyrin repeat
NAME: ankyrin repeat
SITE: 1909-1939
ankyrin repeat
NAME: ankyrin repeat
SITE: 1943-1972
ankyrin repeat
NAME: ankyrin repeat
SITE: 1976-2005
ankyrin repeat
NAME: ankyrin repeat
SITE: 2009-2038
Ser phosphorylation site {S2070}
Thr phosphorylation site {T2074}
Ser phosphorylation site {S2078}
Ser phosphorylation site {S2081}
Thr phosphorylation site {T2097}
serine-rich region {2426-2429}
MOTIF: serine residue (SEVERAL)
Database Correlations
OMIM correlations
MORBIDMAP 600275
UniProt Q04721
PFAM correlations
Entrez Gene 4853
Kegg hsa:4853
References
- UniProt :accession Q04721
- Atlas of Genetics & Cytogenetics in Oncology & Haematology
http://atlasgeneticsoncology.org/genes/NOTCH2ID41556ch1p12.html
- GeneReviews
https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOTCH2